Screening for Diabetes and Prediabetes

Laura J. Gray; Andrew Willis; David Webb; Melanie J. Davies; Kamlesh Khunti

doi:10.1007/978-3-319-27317-4_12-1

Screening for Diabetes and Prediabetes

Laura J. Gray
, Andrew Willis
, David Webb
, Melanie J. Davies
, Kamlesh Khunti

University of Leicester

Research output: Chapter in Book/Report/Conference proceedings › Chapter › peer-review

Abstract

Type 2 Diabetes and Prediabetes are serious conditions which can lead to early morbidity and mortality. The numbers of people with Type 2 Diabetes and Prediabetes are increasing and by 2040 it is estimated that there will be 642 million cases of diabetes alone worldwide, with many more people having Prediabetes. Type 2 diabetes can remain undiagnosed for many years and therefore screening can bring forward diagnosis, allowing treatment to be started earlier which may reduce diabetes related complications. Type 2 Diabetes is preventable in those with Prediabetes and therefore screening can be used to identify those with Prediabetes for inclusion in prevention programmes. In this chapter we consider the evidence for screening for both Type 2 Diabetes and Prediabetes, using case studies throughout to highlight issues.

Original language	English
Title of host publication	Endocrinology (Switzerland)
Publisher	Springer Science and Business Media Deutschland GmbH
DOIs	https://doi.org/10.1007/978-3-319-27317-4_12-1
Publication status	Published - 2018
Externally published	Yes

Publication series

Name	Endocrinology (Switzerland)
ISSN (Print)	2510-1927
ISSN (Electronic)	2510-1935

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Prediabetes
Prevention
Screening
Type 2 Diabetes Mellitus

Access to Document

10.1007/978-3-319-27317-4_12-1

Cite this

@inbook{e359402ff7de4db5bedb10a5b9670f81,

title = "Screening for Diabetes and Prediabetes",

abstract = "Type 2 Diabetes and Prediabetes are serious conditions which can lead to early morbidity and mortality. The numbers of people with Type 2 Diabetes and Prediabetes are increasing and by 2040 it is estimated that there will be 642 million cases of diabetes alone worldwide, with many more people having Prediabetes. Type 2 diabetes can remain undiagnosed for many years and therefore screening can bring forward diagnosis, allowing treatment to be started earlier which may reduce diabetes related complications. Type 2 Diabetes is preventable in those with Prediabetes and therefore screening can be used to identify those with Prediabetes for inclusion in prevention programmes. In this chapter we consider the evidence for screening for both Type 2 Diabetes and Prediabetes, using case studies throughout to highlight issues.",

keywords = "Prediabetes, Prevention, Screening, Type 2 Diabetes Mellitus",

author = "Gray, \{Laura J.\} and Andrew Willis and David Webb and Davies, \{Melanie J.\} and Kamlesh Khunti",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing AG, part of Springer Nature 2018.",

year = "2018",

doi = "10.1007/978-3-319-27317-4\_12-1",

language = "English",

series = "Endocrinology (Switzerland)",

publisher = "Springer Science and Business Media Deutschland GmbH",

booktitle = "Endocrinology (Switzerland)",

address = "Germany",

}

TY - CHAP

T1 - Screening for Diabetes and Prediabetes

AU - Gray, Laura J.

AU - Willis, Andrew

AU - Webb, David

AU - Davies, Melanie J.

AU - Khunti, Kamlesh

PY - 2018

Y1 - 2018

N2 - Type 2 Diabetes and Prediabetes are serious conditions which can lead to early morbidity and mortality. The numbers of people with Type 2 Diabetes and Prediabetes are increasing and by 2040 it is estimated that there will be 642 million cases of diabetes alone worldwide, with many more people having Prediabetes. Type 2 diabetes can remain undiagnosed for many years and therefore screening can bring forward diagnosis, allowing treatment to be started earlier which may reduce diabetes related complications. Type 2 Diabetes is preventable in those with Prediabetes and therefore screening can be used to identify those with Prediabetes for inclusion in prevention programmes. In this chapter we consider the evidence for screening for both Type 2 Diabetes and Prediabetes, using case studies throughout to highlight issues.

AB - Type 2 Diabetes and Prediabetes are serious conditions which can lead to early morbidity and mortality. The numbers of people with Type 2 Diabetes and Prediabetes are increasing and by 2040 it is estimated that there will be 642 million cases of diabetes alone worldwide, with many more people having Prediabetes. Type 2 diabetes can remain undiagnosed for many years and therefore screening can bring forward diagnosis, allowing treatment to be started earlier which may reduce diabetes related complications. Type 2 Diabetes is preventable in those with Prediabetes and therefore screening can be used to identify those with Prediabetes for inclusion in prevention programmes. In this chapter we consider the evidence for screening for both Type 2 Diabetes and Prediabetes, using case studies throughout to highlight issues.

KW - Prediabetes

KW - Prevention

KW - Screening

KW - Type 2 Diabetes Mellitus

UR - https://www.scopus.com/pages/publications/85164766011

U2 - 10.1007/978-3-319-27317-4_12-1

DO - 10.1007/978-3-319-27317-4_12-1

M3 - Chapter

AN - SCOPUS:85164766011

T3 - Endocrinology (Switzerland)

BT - Endocrinology (Switzerland)

PB - Springer Science and Business Media Deutschland GmbH

ER -

Screening for Diabetes and Prediabetes

Abstract

Publication series

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this